Konek­sa lands new round of funds to de­vel­op app-based dig­i­tal bio­mark­er tech

Imag­ine a world in which you can grab an iPhone, per­form a quick se­ries of tests that take no longer than a sec­tion of lan­guage learn­ing in the Duolin­go app, and test your­self for a myr­i­ad of dis­eases, such as Parkin­son’s and mul­ti­ple scle­ro­sis.

The team at Konek­sa Health is de­vel­op­ing that pos­si­bil­i­ty right now, and on Mon­day, an­nounced a $45 mil­lion Se­ries C fi­nanc­ing round to speed up the ex­pan­sion of the pro­gram.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER